A randomized phase III trial of adjuvant chemotherapy versus concurrent chemoradiotherapy for postoperative cervical cancer: Japanese Gynecologic Oncology Group study (JGOG1082)

Akiko Furusawa,Miho Watanabe,Munetaka Takekuma,Shin Nishio,Yuichiro Miyamoto,Koji Nishino,Tomoka Usami,Ryoichi Yoshimura,Mikio Mikami,Takayuki Enomoto,Keita Mori,Eiji Kondo

doi:10.1136/ijgc-2020-002344

A randomized phase III trial of adjuvant chemotherapy versus concurrent chemoradiotherapy for postoperative cervical cancer: Japanese Gynecologic Oncology Group study (JGOG1082)

Akiko Furusawa, Miho Watanabe + Show 10 more

https://doi.org/10.1136/ijgc-2020-002344

Copy DOI

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society	Publication Date: Mar 4, 2021
Citations: 14

Affiliation: Tokyo Metropolitan Komagome Hospital, Chiba University, Shizuoka Cancer Center, Kurume University, Ehime University, Tokyo Medical and Dental University, Tokai University, Niigata University, Mie University

#Adjuvant Concurrent Chemoradiotherapy #Adjuvant Chemoradiotherapy + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

BackgroundThe standard treatment for stage IB–IIB cervical cancer is radiotherapy or radical hysterectomy; after radical hysterectomy, adjuvant concurrent chemoradiotherapy is recommended for patients with high risk factors. However, adjuvant concurrent...

Full Text